Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
covid-19_vaccines:adverse_events:myopericarditis [2022/01/22 00:28] robin [COVID-19 Vaccine Associated Myopericarditis and PeriMyocarditis] | covid-19_vaccines:adverse_events:myopericarditis [2022/01/22 22:33] (current) robin [Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Myopericarditis] |
---|
* Enhanced surveillance for myocarditis outcomes after mRNA COVID-19 vaccination in VAERS case reports is ongoing | * Enhanced surveillance for myocarditis outcomes after mRNA COVID-19 vaccination in VAERS case reports is ongoing |
| |
===== Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Lymphadenopathy ===== | ===== Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Myopericarditis ===== |
| |
[[https://www.sciencedirect.com/science/article/pii/S002234762100665X|Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents ]] | [[https://www.sciencedirect.com/science/article/pii/S002234762100665X|Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents ]] |
| |
[[https://pubmed.ncbi.nlm.nih.gov/34133825/|Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report]] | [[https://pubmed.ncbi.nlm.nih.gov/34133825/|Myopericarditis in a previously healthy adolescent male after COVID-19 vaccination: Case report]] |
| |
| [[https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx|Transient cardiac injury in adolescents receiving the BNT162b2 mRNA COVID-19 vaccine ]] |
| |
| ===== Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Perimyocarditis ===== |
| |
| [[https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543|Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine]] |
| |
| [[https://pubmed.ncbi.nlm.nih.gov/34319393/|Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine]] |
| |
| [[https://pubmed.ncbi.nlm.nih.gov/34447639/|Unusual presentation of acute perimyocarditis after modern SARS-COV-2 mRNA-1237 vaccination]] |
| |
| [[https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183|Perimyocarditis after the first dose of mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 vaccine in a young healthy male: case report]] |
| |
| [[https://pubmed.ncbi.nlm.nih.gov/34515024/|Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine]] |
| |
| [[https://pubmed.ncbi.nlm.nih.gov/34866957/|Perimyocarditis after vaccination with COVID-19]] |
| |
| [[https://www.ncbi.nlm.nih.gov/pubmed/34866957|Perimyocarditis Following COVID-19 Vaccination. Clin Med Insights Cardiol]] |
| |
| [[https://www.ncbi.nlm.nih.gov/pubmed/34270752]Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc]] |
| |
| [[https://www.ncbi.nlm.nih.gov/pubmed/34447639Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination. Cureus]] |
| |
| [[https://www.ncbi.nlm.nih.gov/pubmed/34348657|Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord]] |
| |
| |
| |
| |
| |